FDA approves new indication for Gilotrif in EGFR mutation-positive NSCLC
The FDA has approved a supplemental New Drug Application for…
The FDA has approved a supplemental New Drug Application for Gilotrif for the first-line treatment of patients with metastatic non-small cell lung cancer...